At a glance
ClinicalIndex Comparison Record- ✓Hemophilia A patients receiving ADYNOVATE treatment
- ✕Patients not receiving ADYNOVATE
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ADYNOVATE Drug Use-Results Survey
In Brief
An observational study evaluating ADYNOVATE for Hemophilia A. Completed, enrolled 135 participants across 52 sites.
Detailed Summary
The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients: 1. Unexpected adverse drug reactions 2. Occurrence of adverse drug reactions in the actual clinical use 3. Factors that may affect safety and efficacy 4. Occurrence of Factor VIII inhibitor development in patients with coagulation factor VIII deficiency (hereinafter hemophilia A) 5. Safety and efficacy for hemophilia A patients who received routine prophylactic therapy and on-demand therapy
Study Details
Timeline
Interventions
Antihemophilic Factor (Recombinant), PEGylated